3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
6
Osteosarcoma
6
Neuroblastoma
6
Leukemia, Myeloid, Acute
6
Glioma
6
Rhabdoid Tumor
5
Neoplasm Metastasis
5
Lymphoma, Non-Hodgkin
5
Hepatoblastoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Multiple Myeloma
4
Medulloblastoma
4
Histiocytosis, Langerhans-Cell
4
Ependymoma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Sarcoma, Ewing
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Central Nervous System Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Mouth Neoplasms
2
Melanoma
2
Interventions
Cyclophosphamide
12
fludarabine
8
Rituximab
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
zanubrutinib
3
Vincristine
3
Doxorubicin
3
Dexamethasone
3
tazemetostat
2
tafasitamab
2
pembrolizumab
2
glofitamab
2
etoposide phosphate
2
acalabrutinib
2
Prednisone
2
Nivolumab
2
Leukapheresis
2
Gemcitabine
2
Etoposide
2
Cisplatin
2
venetoclax
1
varlilumab
1
polatuzumab vedotin
1
pirtobrutinib
1
obinutuzumab
1
loncastuximab tesirine
1
ibrutinib
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell
×
X-Rays
×
30 days
×
Clear all
No trials found.